IOL launch and Q&A with a negotiation pro lead early 2021 news
A new IOL from Alcon and a Q&A with Lisa M. Nijm, MD, JD, led Healio/OSN’s coverage in the first weeks of 2021.
Read and watch the best-performing content of the new year below.
Alcon launches Vivity IOL
Alcon has launched the AcrySof IQ Vivity IOL, the first non-diffractive extended depth of focus IOL in the U.S. Watch here.
Q&A: Nijm encourages physicians to elevate their negotiation skills with MDNegotiation.com
The ever-changing landscape of medicine makes it more important than ever for physicians to advocate for patients, their practices and themselves, according to Lisa M. Nijm, MD, JD. Read more.
First patient dosed in AXT107 clinical trial for DME
The first patient has been dosed in a phase 1/2a clinical trial of AXT107 to evaluate the safety and bioactivity of the therapy in patients with diabetic macular edema, according to a press release from AsclepiX Therapeutics. Read more.
Kala launches Eysuvis for short-term dry eye treatment
Eysuvis is now available for the short-term treatment of dry eye disease, according to a press release from Kala Pharmaceuticals. Read more.
Surgeons discuss how to address astigmatism during cataract surgery
Correcting astigmatism is an important part of cataract surgery, especially as the goals of modern cataract surgery have evolved to mirror that of refractive surgery, responding to heightened expectations of patients. Read more.